Impact of pretransplant comorbidities on alemtuzumab-based reduced-intensity conditioning allogeneic hematopoietic SCT for patients with high-risk myelodysplastic syndrome and AML

✍ Scribed by Lim, Z Y; Ingram, W; Brand, R; Ho, A; Kenyon, M; Devereux, S; Marsh, J; Mufti, G J; Pagliuca, A

• Book ID: 109840829
• Publisher: Nature Publishing Group
• Year: 2009
• Tongue: English
• Weight: 357 KB
• Volume: 45
• Category: Article
• ISSN: 0007-1188
• DOI: 10.1038/bmt.2009.236